Related Experiment Video
Updated: Aug 11, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Epidemiology and natural history of hepatitis B
1Liver Disease and Hepatitis Program, Alaska Native Medical Center, Anchorage, Alaska, USA. bdm9@cdc.gov
Insights
Hepatitis B virus (HBV) infection affects millions globally, posing a lifelong risk for liver cancer and cirrhosis. Early detection and regular monitoring are crucial for managing chronic HBV and preventing severe liver disease.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Hepatitis B virus (HBV) infects 400 million worldwide, causing chronic infections with lifelong risks of cirrhosis and hepatocellular carcinoma (HCC).
- Many infected individuals are unaware of their status, and few receive regular monitoring for disease progression.
- High-risk populations, including immigrants from endemic regions, require targeted screening and vaccination strategies.
Purpose of the Study:
- To highlight the global burden of Hepatitis B virus (HBV) infection.
- To emphasize the importance of screening, vaccination, and monitoring for chronic HBV.
- To discuss factors influencing HBV natural history and the role of antiviral therapy.
Main Methods:
- Review of current epidemiological data on HBV prevalence and chronic infection.
- Analysis of factors influencing the natural history of chronic HBV infection.
- Evaluation of recent findings on antiviral therapy efficacy and the necessity of lifelong monitoring.
Main Results:
- Chronic HBV infection presents a significant global health challenge with substantial risks of severe liver disease.
- Disease progression is multifactorial, influenced by viral, host, and environmental elements.
- Antiviral therapies show promise in reducing complications for selected patients, underscoring the need for ongoing management.
Conclusions:
- Lifelong monitoring for active liver disease and HCC is essential for individuals with chronic HBV infection.
- Targeted screening and vaccination in high-risk groups are critical public health interventions.
- Understanding the dynamic nature of HBV and the impact of therapy informs clinical management strategies.
Abstract:
Hepatitis B virus (HBV) is a common viral pathogen that currently infects an estimated 4 million people worldwide, including 400 million who have chronic infection. Persons with chronic HBV infection are at a lifelong risk of developing hepatocellular carcinoma (HCC) or cirrhosis, or both. Many persons with HBV are unaware that they carry the infection, and, of those who are chronically infected, only a minority receives routine, scheduled follow-up to monitor their disease status. Persons from high-risk populations, especially immigrants from nations where hepatitis B is highly endemic, should be tested for HBV seromarkers and should be vaccinated if they are found to be negative. The natural history of chronic HBV is a dynamic one: patients can fluctuate between periods of active liver inflammation and periods of inactive disease. Disease progression is influenced by various factors, including viral genotype and specific mutations, demographic features, concurrent viral infections, and social and environmental factors. Recent data suggest that antiviral therapy can decrease the risk of liver decompensation and liver-related death and reduce the risk of HCC in selected individuals with active liver disease and severe fibrosis. Persons identified with chronic HBV infection need lifelong, regular monitoring for the development of active liver disease and HCC.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Viruses with RNA Genomes
Infectious Diseases and Their Occurrence
Yellow Fever
Hepatitis
Viral Hepatitis I: Introduction

